The US company Emerging Healthcare Solutions Inc. (EHSI), purchased the Panamanian company Células Genética.
In March this year, the companies signed an agreement to share profits, through which EHSI injected $ 1.8 million into the Panamanian company.
A few days ago, Células Genéticas announced the purchase of a license to develop and commercialize the Rutherford Procedure, a technique for organ regeneration.
español
